• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Cannabis Market
Cannabis News
Cannabis Stocks
  • Cannabis Market
  • Cannabis News
  • Cannabis Stocks
cannabis investing

MBLL Selects Seven Oaks Cannabis Products for Sale in Manitoba

Anwesha Sengupta
Jun. 29, 2018 07:41AM PST
Cannabis Investing News

Seven Oaks is excited to announce that its brand will be available in Manitoba through Beleave Inc. (CSE:BE) who has been selected by the Manitoba Liquor and Lotteries Corporation (MBLL) to supply cannabis to Manitoba retailers

Seven Oaks is excited to announce that its brand will be available in Manitoba through Beleave Inc. (CSE:BE) who has been selected by the Manitoba Liquor and Lotteries Corporation (MBLL) to supply cannabis to Manitoba retailers making Seven Oaks one of the first cannabis brands available to consumers upon legalization. The brand is strongly rooted in Manitoba with its founders being proud Metis from Winnipeg and the name itself being a reference to a historical Metis battle site.

“We wanted to develop a brand that was a modern interpretation of the Metis spirit of freedom and adventure. We’re proud to be able to roll-out in our home province on day one. We’re making history,” said Seven Oaks’ Co-FounderGrant McLeod.

Seven Oaks will have three hybrid strains containing limonene and pinene that were selected for their association with uplifting effects. Products will initially include pouches of 1 g and 3.5 g of flower and 1 g pre- rolled joints, while tinctures and half-gram pre-rolled packs will be coming in the near future.

“Seven Oaks is for professionals like myself who use cannabis regularly while having active, productive lives. I’m looking for something uplifting that I can be functional with, not something that’s going to make me too foggy,” said Grant.

Specific details of price and quantities are still being worked out. Seven Oaks will continue to work closely with MBLL, and all other stakeholders to ensure that we collectively deliver a cannabis system that provides professional and responsible access to high quality recreational cannabis.

Seven Oaks’ cannabis supply is coming from Beleave who has a well-established track record of growing superior cannabis without the use of pesticides providing a secure supply of high grade cannabis for the Seven Oaks brand. Beleave Inc. trades on the CSE as BE and the OTCQX as BLEVF.

Click here to connect with Beleave Inc. (CSE:BE) for an Investor Presentation.

Source: www.newswire.ca

cannabis investing
The Conversation (0)

Go Deeper

AI Powered
Cannabis Weekly Round-Up: California Votes for Cannabis Banks

Cannabis Weekly Round-Up: California Votes for Cannabis Banks

Cannabis Investing

Cannabis Weekly Round-Up: Lift Cannabis Expo Takes Charge

Latest News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Cannabis Investing News Stocks

extractX

extractX (None)
More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES